Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03368664 |
|---|---|
| Brief Title: | A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT (LemKids) |
| First Submitted : | November 2, 2017 |
| First Submitted that Met QC Criteria : | December 5, 2017 |
| First Posted : | December 11, 2017 |
| Results First Submitted : | May 3, 2022 |
| Results First Posted with QC Comments : | May 27, 2022 |
| Results First Submitted that Met QC Criteria : | June 16, 2022 |
| Results First Posted : | July 12, 2022 |
| Last Update Submitted that Met QC Criteria : | June 16, 2022 |
| Last Update Posted : | July 12, 2022 |